PPP2R2A and breast cancer: In the luminal-like BC subgroup, in both cohorts, PPP2R2A (B55α)-/ low is significantly associated with steeper mortality curves, thus further validating the scoring methodology used and the association between PPP2R2A (B55α) expression status and survival in this subset of patients (Figure 5).